MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress » Clinical Trials and Therapy in Movement Disorders (non-PD) (non-Dystonia)

Meeting: 2022 International Congress

A phase 2b, randomized, dose-response study of SAGE-324/BIIB124 for the treatment of essential tremor: KINETIC 2 trial in progress

R. Pahwa, A. Ellenbogen, R. Elble, K. Bankole, T. Dam, J. Fratantonio, J. Gaiha-Rohrbach, M. Qin, S. Garafola, M. Gerbasi, H. Colquhoun (Kansas City, USA)

Clinical effectiveness and economic impact of transcutaneous afferent patterned stimulation therapy for essential tremor in a real-world setting: protocol for a pragmatic trial

D. Dai, J. Fernandes, LA. Ramel, H. Coetzer, V. Zraick, A. Samiian, L. Hennum (Woonsocket, USA)

Effects of venlafaxine on neuropsychiatric and motor symptoms in patients with progressive supranuclear palsy

M. Zeitzschel, M. Maheu, T. Donner, C. Gerloff, A. Gulberti, M. Pötter-Nerger (Hamburg, Germany)

Electrical stimulation of muscle afferents for tremor reduction in essential tremor patients

M. González Sánchez, JR. Pérez Sánchez, A. Pascual Valdunciel, F. Oliveira Barroso, S. Muceli, B. Adán-Barrientos, V. Escobar-Segura, M. Ki Jung, A. Muñoz González, A. Schneider, KP. Hoffmann, D. Farina, JL. Pons, FJ. Grandas Pérez (Madrid, Spain)

Expanding the armamentarium of clinical use of apomorphine in movement disorders.

S. Bansal, JR. Chai, M. Jog (London, Canada)

Is there a role for safinamide in atypical parkinsonian syndromes?

A. Silva, M. Rodrigues (Braga, Portugal)

Patient-Specific Outcomes of Transcutaneous Afferent Patterned Stimulation with Varying Frequencies for Essential Tremor and Parkinson’s Disease

A. Kent, H. Kim, D. Khosla, K. Rosenbluth (Foster City, USA)

Safety and Efficacy of Verdiperstat, a Novel Myeloperoxidase Inhibitor, in MSA

I. Qureshi, V. Wirtz, L. Brady, J. Ellison, A. Ellenbogen, R. Freeman, G. Höglinger, H. Kaufmann, A. Lang, P. Low, W. Meissner, P. Millar Vernetti, H. Morris, J. Palma, S. Perlman, W. Poewe, J. Schmahmann, K. Seppi, W. Singer, S. Vernino, G. Wenning (New Haven, USA)

Safety and tolerability of Nilotinib in patients with Huntington’s disease

K. Anderson (Washington, USA)

Safety, Target Engagement and Effects of Bosutinib in Dementia with Lewy Bodies

F. Pagan, Y. Torres-Yaghi, M. Hebron, R. Turner, B. Wilmarth, S. Matar, D. Ferrante, J. Ahn, C. Moussa (Washington, USA)

Tissue Frataxin Increases After Administration of CTI-1601, a Frataxin Replacement Therapy in Development for the Treatment of Friedreich’s Ataxia

D. Bettoun, T. Galas, D. Schecter, N. Ruiz, R. Clayton, J. Farmer (Bala Cynwyd, USA)

Treating Upper Limb Spasticity With OnabotulinumtoxinA: Subgroup Analysis of US Practice Patterns From the ASPIRE Study

G. Francisco, W. Feng, M. Munin, K. Ngo, M. Schwartz, M. Sadeghi, A. Zuzek, A. Esquenazi (Houston, USA)

« View all sessions from the 2022 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley